Nido Bio
United States · $109.0M raised
- Business Model
- B2B
- Website
- nidobio.com
- Total Funding
- $109.0M
- Last Round
- $109.0M SeedMay 2023
- Rounds
- 1
About
Develops oral small molecules for neurodegeneration targets
Summary
Nido Bio is a Biotech company based in United States. It has raised $109.0M in total across 1 round, most recently a $109.0M Seed round in May 2023. Investors include 5AM Ventures, Eli Lilly and Bioluminescence Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...